GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lipidor AB (OSTO:LIPI) » Definitions » EV-to-FCF

Lipidor AB (OSTO:LIPI) EV-to-FCF : -18.36 (As of Apr. 08, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Lipidor AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Lipidor AB's Enterprise Value is kr198.42 Mil. Lipidor AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was kr-10.81 Mil. Therefore, Lipidor AB's EV-to-FCF for today is -18.36.

The historical rank and industry rank for Lipidor AB's EV-to-FCF or its related term are showing as below:

OSTO:LIPI' s EV-to-FCF Range Over the Past 10 Years
Min: -33.62   Med: -7.88   Max: 1.8
Current: -17.19

During the past 8 years, the highest EV-to-FCF of Lipidor AB was 1.80. The lowest was -33.62. And the median was -7.88.

OSTO:LIPI's EV-to-FCF is ranked worse than
100% of 547 companies
in the Drug Manufacturers industry
Industry Median: 24.12 vs OSTO:LIPI: -17.19

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-08), Lipidor AB's stock price is kr0.2565. Lipidor AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.189. Therefore, Lipidor AB's PE Ratio (TTM) for today is At Loss.


Lipidor AB EV-to-FCF Historical Data

The historical data trend for Lipidor AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipidor AB EV-to-FCF Chart

Lipidor AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial -20.45 -13.37 -0.31 -0.87 -10.14

Lipidor AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.33 -0.87 -1.34 -1.10 -10.14

Competitive Comparison of Lipidor AB's EV-to-FCF

For the Drug Manufacturers - General subindustry, Lipidor AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipidor AB's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lipidor AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Lipidor AB's EV-to-FCF falls into.


;
;

Lipidor AB EV-to-FCF Calculation

Lipidor AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=198.423/-10.809
=-18.36

Lipidor AB's current Enterprise Value is kr198.42 Mil.
Lipidor AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-10.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lipidor AB  (OSTO:LIPI) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Lipidor AB's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.2565/-0.189
=At Loss

Lipidor AB's share price for today is kr0.2565.
Lipidor AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.189.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Lipidor AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Lipidor AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Lipidor AB Business Description

Traded in Other Exchanges
N/A
Address
c/o Ekonomistubben AB, Box 55931, Stockholm, SWE, 102 16
Lipidor AB is a pharmaceutical development company with a pipeline of drug development projects in the preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections, and atopic dermatitis.

Lipidor AB Headlines

No Headlines